Blood transfusion in care of patients with Visceral Leishmaniasis: a review of practices in therapeutic efficacy studies
Preprint
Abstract
Anaemia is a common presentation feature in patients with visceral leishmaniasis (VL). Blood transfusion remains an important aspect of patient management in VL. However, triggers considered for making decisions on transfusion are poorly understood. This review is based on the Infectious Diseases Data Observatory (IDDO) VL clinical trials library, a database of all published efficacy studies since 1980 and has indexed 160 published trials (1980–2021). Description of blood transfusion was reported in 16 (10.1%) trials (n=3,459 patients). Transfusion was initiated solely based on haemoglobin (Hb) measurement in 9 studies, using a combination of Hb and other health conditions (epistaxis, poor health, or clinical instability) in 3 studies, and the criteria was unclear in 4 studies; Hb threshold ranged from 3-8 g/dL. Overall, the number of patients receiving transfusion was explicitly reported in 10 trials (n=2,421 patients enrolled). Of these, 217 patients underwent transfusion; 58 before treatment initiation and 46 during treatment or the follow-up phase, and the time of transfusion was unclear in 113. The median proportion of patients who received a transfusion in a study was 8.0% [Interquartile range (IQR): 4.7% to 47.2%; range: 0-100%; n=10 studies]. This review describes the variation in current clinical practice and is an important initial step in policy/guideline development, where both the patient’s haemoglobin concentration and clinical status must be considered.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Treatment of Anemia in Patients With Heart DiseaseAnnals of Internal Medicine, 2013
- Guidelines on the management of anaemia and red cell transfusion in adult critically ill patientsBritish Journal of Haematology, 2012
- Improving Outcome of Treatment of Kala-Azar by Supplementation of Amphotericin B with Physiologic Saline and Potassium ChlorideThe American Journal of Tropical Medicine and Hygiene, 2010
- Maternal and perinatal outcomes of visceral leishmaniasis (kala‐azar) treated with sodium stibogluconate in eastern SudanInternational Journal of Gynecology & Obstetrics, 2009
- Visceral leishmaniasis in Malta---an 18 year paediatric, population based studyArchives of Disease in Childhood, 2000
- A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical CareJournal of Urology, 1999
- Effect of blood transfusion on survival among children in a Kenyan hospitalThe Lancet, 1992
- Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised studyBMJ, 1988
- Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis)Transactions of the Royal Society of Tropical Medicine and Hygiene, 1984
- A review of kala-azar in Malta from 1947 to 1962Transactions of the Royal Society of Tropical Medicine and Hygiene, 1964